Is renal biopsy always necessary to start immunosuppressive therapy in lupus nephritis?
Objective: Most of the patients with proliferative lupus nephritis (LN) have high titer of anti-dsDNA antibody and low complement levels. In this study, we tried to predict proliferative LN with serological profile. Methods: This prospective study was conducted in fifty pateints with known systemic...
Saved in:
Main Authors: | Vasudevan Chelliah, V Balaraman, S Ilango, S Ramesh, V Kannan Bhaba, D Shivakumar |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2017-01-01
|
Series: | Indian Journal of Rheumatology |
Subjects: | |
Online Access: | http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2017;volume=12;issue=1;spage=12;epage=16;aulast=Chelliah |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Outcome of therapy in biopsy proven lupus nephritis with cyclophosphamide or mycophenolate: Registry data from a South Indian tertiary care center
by: Keerthi Talari, et al.
Published: (2017-01-01) -
Cyclophosphamide and mycophenolate mofetil as induction therapy in lupus nephritis
by: Božić-Majstorović Ljubinka, et al.
Published: (2024-01-01) -
M1 and M2 Macrophage Polarization Correlates with Activity and Chronicity Indices in Lupus Nephritis
by: Chutima Chavanisakun, et al.
Published: (2025-01-01) -
STAT3 inhibition ameliorates renal interstitial inflammation in MRL/lpr mice with diffuse proliferative lupus nephritis
by: Jianfen Zhu, et al.
Published: (2024-12-01) -
Case report: Single infusion of combined anti-CD20 and anti-CD38 monoclonal antibodies in pediatric refractory lupus nephritis
by: Decimo Silvio Chiarenza, et al.
Published: (2025-01-01)